Search Results 141-150 of 17975 for Parkinson's disease
Rotigotine transdermal patch is used to treat Parkinson disease. It is a dopamine agonist that works on the nervous system to help treat the symptoms of ...
Trihexyphenidyl is used alone or together with other medicines (e.g., levodopa) to treat Parkinson's disease. By improving muscle control and reducing ...
... Parkinson's disease. Participation eligibility. Participant eligibility ... Participant eligibility includes age, gender, type and stage of disease, and previous ...
... and mental changes) associated with Alzheimer's disease or mild to moderate dementia associated with Parkinson's disease. Rivastigmine will not cure these ...
Another risk factor for dystonia is having a condition that causes dystonia, such as Parkinson's disease or Huntington's disease. Complications. Depending on ...
This study will investigate the effects of Real-Time Feedback Training and treadmill training to improve gait posture in subjects with Parkinson's Disease.
The purpose of this study is to compare treadmill walking and over ground walking gait characteristics in people diagnosed with Parkinson's disease.
Mayo Clinic's Translational Cell Biology of Parkinson's Disease Lab led by Wolfdieter Springer, Ph.D., includes an expert team of faculty and staff.
Children—Use and dose must be determined by your doctor. For oral dosage form (tablets):. For Parkinson disease: Adults—At first, 0.125 milligram (mg) 3 times ...
About this study. This randomized, multicenter, placebo-controlled, double-blind study will evaluate the efficacy and safety of inhaled CVT 301 compared ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.